Region: Global
Category: Life Sciences

Global Life Sciences

(49,115 reports matching your criteria)
  • Antimicrobial Susceptibility Testing

    ... by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Manual Antimicrobial Susceptibility Testing Products, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach ... Read More

  • Automotive Upholstery

    ... at a CAGR of 7.5% over the analysis period 2023-2030. Seat Cover Application, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$2.7 Billion by the end ... Read More

  • Ultraviolet Germicidal Irradiation (UVGI)

    ... reach US$1.2 Billion by 2030, growing at a CAGR of 11.3% over the analysis period 2023-2030. Air Disinfectant, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach ... Read More

  • COVID-19 Testing

    ... at a CAGR of -16.1% over the analysis period 2023-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.9% CAGR and reach US$3.9 Billion by the end ... Read More

  • 2024 Global Surgical Appliance And Supplies Manufacturing, Nsk, Total Products Markets (2030 Outlook)

    ... for 46 countries (Wharry Sharpe Research) The Global Products Markets Outlook reports provide product market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) ... Read More

  • Radiation Therapy Equipment

    ... by 2030, growing at a CAGR of 6.5% over the analysis period 2023-2030. External Beam Radiation Therapy Equipment, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach ... Read More

  • Medicated Skin Care Products

    ... reach US$9.2 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2023-2030. Medicated Cleansers, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach ... Read More

  • Molecular Cytogenetics

    ... at a CAGR of 8.8% over the analysis period 2023-2030. Molecular Cytogenetics Consumables, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$2.0 Billion by the end ... Read More

  • Form Fill and Sealing (FFS) Equipment

    ... the year 2023, is expected to reach US$13.7 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2023-2030. Horizontal FFS Equipment, one of the segments analyzed in the report, is expected ... Read More

  • Ginseng

    ... of 10.2% over the analysis period 2023-2030. Asian Ginseng, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$11.2 Billion by the end of the analysis period. ... Read More

  • Home Health Hubs

    ... by 2030, growing at a CAGR of 33.6% over the analysis period 2023-2030. High-Acuity Patient Monitoring, one of the segments analyzed in the report, is expected to record a 34.9% CAGR and reach US$5.0 Billion ... Read More

  • Medical Animation

    ... at a CAGR of 19.8% over the analysis period 2023-2030. Oncology Therapeutic Area, one of the segments analyzed in the report, is expected to record a 19.5% CAGR and reach US$503.4 Million by the end ... Read More

  • Proteomics

    ... of 10.1% over the analysis period 2023-2030. Proteomics Reagents, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$49.2 Billion by the end of the analysis period. ... Read More

  • Foot Care Products

    ... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Foot Creams, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$1.4 Billion by ... Read More

  • Cardiac POC Testing Devices

    ... reach US$2.2 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. Cardiac Markers Test, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and ... Read More

  • Healthcare Facilities Management

    ... by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Soft Services, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$163.1 Billion by ... Read More

  • Healthcare Analytics

    ... at a CAGR of 23.2% over the analysis period 2023-2030. Descriptive Analytics, one of the segments analyzed in the report, is expected to record a 19.7% CAGR and reach US$86.5 Billion by the end of ... Read More

  • Neuromodulation

    ... of 9.1% over the analysis period 2023-2030. Spinal Cord Stimulation, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$5.4 Billion by the end of the analysis ... Read More

  • Pneumatic Compression Therapy

    ... by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Pneumatic Compression Sleeves, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$483.0 Million ... Read More

  • Rheumatoid Arthritis Diagnosis Tests

    ... reach US$944.9 Million by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Diagnostic Laboratories End-Use, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and ... Read More

  • Sodium Borohydride

    ... at a CAGR of 6.3% over the analysis period 2023-2030. Pharmaceuticals End-Use, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$733.5 Million by the end of ... Read More

  • Global Osteoporosis Drugs Market Report by Route of Administration (Injectable, Oral, Others) Product Type (Rank Ligand Inhibitor, Bisphosphonates, Calcitonin, Parathyroid Hormone Therapy (PTH), Selective Estrogen Receptor Modulators (SERMs), Sclerostin Inhibitor, Others) Countries and Company Analysis, 2024-2032

    ... 2024-2032 Osteoporosis Drugs Market Analysis The osteoporosis drugs market is expected to over US$ 25.53 billion by 2032 from US$ 17.43 billion by 2023, with a CAGR growth of 4.33% from 2024 to 2032 because ... Read More

  • Contraceptives

    ... of 6.2% over the analysis period 2023-2030. Contraceptive Drugs, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$26.0 Billion by the end of the analysis period. ... Read More

  • Hot and Cold Therapy Packs

    ... is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Cold Packs, one of the segments analyzed in the report, is expected to record a 6.9% ... Read More

  • Orthopedic Prosthetic Implants

    ... by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Knee Prosthesis, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$14.9 Billion by ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings